X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2417) 2417
Newsletter (406) 406
Publication (181) 181
Book Chapter (20) 20
Book Review (15) 15
Newspaper Article (14) 14
Magazine Article (9) 9
Trade Publication Article (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
entecavir (2539) 2539
hepatitis b (1540) 1540
humans (1174) 1174
lamivudine (1125) 1125
index medicus (1124) 1124
hepatitis b, chronic - drug therapy (806) 806
gastroenterology & hepatology (801) 801
hepatitis b virus (779) 779
antiviral agents - therapeutic use (758) 758
male (725) 725
female (676) 676
guanine - analogs & derivatives (634) 634
adult (621) 621
middle aged (607) 607
chronic hepatitis b (597) 597
tenofovir (593) 593
treatment outcome (491) 491
care and treatment (484) 484
therapy (472) 472
guanine - therapeutic use (438) 438
hepatitis (434) 434
adefovir dipivoxil (431) 431
research (400) 400
drug therapy (376) 376
hepatitis b virus - genetics (371) 371
interferon (353) 353
adefovir (346) 346
hepatitis b virus - drug effects (342) 342
health aspects (323) 323
antiviral agents (316) 316
infection (314) 314
dna, viral - blood (307) 307
hepatocellular-carcinoma (293) 293
adenine - analogs & derivatives (286) 286
analysis (281) 281
cirrhosis (277) 277
hepatitis b, chronic - virology (266) 266
virology (258) 258
aged (257) 257
infectious diseases (254) 254
resistance (252) 252
hepatitis b e antigens - blood (248) 248
pharmacology & pharmacy (242) 242
lamivudine - therapeutic use (240) 240
antiviral agents - administration & dosage (238) 238
retrospective studies (235) 235
efficacy (230) 230
liver cirrhosis (225) 225
viral load (220) 220
liver (219) 219
management (218) 218
telbivudine (214) 214
medical research (209) 209
risk (208) 208
tenofovir disoproxil fumarate (208) 208
drug resistance (207) 207
medicine, experimental (201) 201
adenine - therapeutic use (200) 200
antiviral therapy (200) 200
virus infection (199) 199
antigens (198) 198
risk factors (198) 198
organophosphonates - therapeutic use (196) 196
drug resistance, viral (192) 192
hepatocellular carcinoma (192) 192
antiviral agents - adverse effects (188) 188
drug therapy, combination (188) 188
dna (182) 182
hepatitis b, chronic - complications (180) 180
deoxyribonucleic acid--dna (179) 179
hbv (174) 174
time factors (171) 171
guanine - administration & dosage (170) 170
hepatology (169) 169
young adult (169) 169
antiviral agents - pharmacology (159) 159
hepatitis b - drug therapy (159) 159
mutation (159) 159
virus diseases (157) 157
patients (152) 152
liver cancer (151) 151
medicine & public health (150) 150
natural-history (150) 150
virus (149) 149
hepatitis b, chronic - blood (141) 141
gastroenterology and hepatology (140) 140
chronic hepatitis-b (138) 138
hepatitis b surface antigens - blood (138) 138
digestive system diseases (136) 136
hepatitis b, chronic - diagnosis (134) 134
dosage and administration (133) 133
hepatitis b e antigen (131) 131
medicine, general & internal (131) 131
liver diseases (129) 129
safety (128) 128
lamivudine therapy (127) 127
hepatitis b virus - immunology (126) 126
nucleoside analogs (125) 125
virus-infection (125) 125
hepatitis b surface antigen (124) 124
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2517) 2517
Korean (225) 225
French (23) 23
Chinese (19) 19
Spanish (19) 19
German (17) 17
Hungarian (14) 14
Japanese (10) 10
Russian (9) 9
Portuguese (5) 5
Turkish (5) 5
Czech (4) 4
Arabic (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Lin, BL
HEPATOLOGY, ISSN 0270-9139, 11/2017, Volume 66, Issue 5, pp. 1706 - 1706
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 10/2019
Journal Article
JOURNAL OF HEPATOLOGY, ISSN 0168-8278, 09/2019, Volume 71, Issue 3, pp. 453 - 455
Journal Article
HEPATOLOGY, ISSN 0270-9139, 11/2017, Volume 66, Issue 5, pp. 1444 - 1453
Whether there is a change of hepatocellular carcinoma (HCC) incidence in chronic hepatitis B patients under long-term therapy with potent nucleos(t)ide... 
PREDICTIVE SCORE | ANTIVIRAL THERAPY | VIRUS INFECTION | CIRRHOSIS | DISOPROXIL FUMARATE | RECEIVING ENTECAVIR | GASTROENTEROLOGY & HEPATOLOGY | PRACTICE GUIDELINES MANAGEMENT
Journal Article
GASTROENTEROLOGY, ISSN 0016-5085, 01/2016, Volume 150, Issue 1, pp. 134 - 134
BACKGROUND & AIMS: Patients chronically infected with the hepatitis B virus rarely achieve loss of serum hepatitis B surface antigen (HBsAg) with the standard... 
Virologic Response | ENTECAVIR | PEGYLATED INTERFERON ALPHA-2A | CONTROLLED TRIAL | VIRUS | Clinical Trial | ADEFOVIR | HBSAG | NATURAL-HISTORY | LAMIVUDINE | HBeAg Seroconversion | THERAPY | TERM-FOLLOW-UP | GASTROENTEROLOGY & HEPATOLOGY | HBV
Journal Article
Clinics and Research in Hepatology and Gastroenterology, ISSN 2210-7401, 2019
Background and aims: We lack population-based studies that identify the role of entecavir (ETV) in extending long-term survival in chronic hepatitis B... 
Chronic hepatitis B | Decompensated liver chirrhosis | Entecavir
Journal Article
Journal of Chemotherapy, ISSN 1120-009X, 05/2019, Volume 31, Issue 4, pp. 209 - 213
Hepatitis B virus (HBV) infections and sequelae present significant health problems worldwide. Two groups of medications are available for chronic HBV... 
Tenofovir | Entecavir | Hepatitis B | INFECTIOUS DISEASES | ONCOLOGY | CHRONIC HEPATITIS-B | CIRRHOSIS | DISOPROXIL FUMARATE | LONG-TERM ENTECAVIR | RISK | PHARMACOLOGY & PHARMACY
Journal Article
대한소화기학회지, ISSN 1598-9992, 2016, Volume 67, Issue 4, p. 216
Entecavir (Baraclude®) is an oral antiviral drug used for the treatment of HBV. Entecavir is a reverse transcriptase inhibitor which prevents the HBV from... 
Polyneuropathies | Entecavir | Hepatitis B
Journal Article
Journal of Gastroenterology and Hepatology (Australia), ISSN 0815-9319, 2019
Hepatocellular carcinoma (HCC) can still develop in chronic hepatitis B (CHB) patients receiving antiviral treatment. Serum Mac-2-binding protein glycosylation... 
chronic hepatitis B | M2BPGi | entecavir | biomarker | hepatocellular carcinoma
Journal Article
by Lee, M and Chung, GE and Lee, JH and Oh, S and Nam, JY and Chang, Y and Cho, H and Ahn, H and Cho, YY and Yoo, JJ and Cho, Y and Lee, DH and Cho, EJ and Yu, SJ and Lee, JM and Kim, YJ and Yoon, JH
HEPATOLOGY, ISSN 0270-9139, 11/2017, Volume 66, Issue 5, pp. 1556 - 1569
Antiplatelet therapy has shown protective effects against hepatocellular carcinoma (HCC) in preclinical studies. However, it is unclear whether antiplatelet... 
SURVIVAL | PATIENTS RECEIVING ENTECAVIR | VIRUS | PLATELETS | PREDICTORS | PREVENTION | GASTROENTEROLOGY & HEPATOLOGY | PRACTICE GUIDELINES MANAGEMENT
Journal Article
GUT, ISSN 0017-5749, 02/2013, Volume 62, Issue 2, pp. 290 - 298
Objective Treatment with peginterferon alpha-2a (PegIFN) for 48 weeks is the standard of care for selected HBeAg-negative patients chronically infected with... 
TRIAL | E-ANTIGEN | LAMIVUDINE | ENTECAVIR | INTERFERON-ALPHA | SUSTAINED RESPONSE | RETREATMENT | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY
Journal Article